108
Views
9
CrossRef citations to date
0
Altmetric
Commentary

Lithium therapy in ALS

, &
Page 122 | Published online: 10 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Mamede de Carvalho & Susana Pinto. (2011) Lithium treatment in amyotrophic lateral sclerosis: do we have enough trials?. Expert Review of Neurotherapeutics 11:12, pages 1693-1698.
Read now

Articles from other publishers (8)

J. Gamez, M. Salvado, A. Martínez de la Ossa & M. Badia. (2016) Lithium for treatment of amyotrophic lateral sclerosis: Much ado about nothing. Neurología (English Edition) 31:8, pages 550-561.
Crossref
J. Gamez, M. Salvado, A. Martínez de la Ossa & M. Badia. (2016) Litio para el tratamiento de la esclerosis lateral amiotrófica: mucho ruido para nada. Neurología 31:8, pages 550-561.
Crossref
Hiroshi Mitsumoto, Benjamin R Brooks & Vincenzo Silani. (2014) Clinical trials in amyotrophic lateral sclerosis: why so many negative trials and how can trials be improved?. The Lancet Neurology 13:11, pages 1127-1138.
Crossref
Paul Wicks, Timothy E Vaughan, Michael P Massagli & James Heywood. (2011) Accelerated clinical discovery using self-reported patient data collected online and a patient-matching algorithm. Nature Biotechnology 29:5, pages 411-414.
Crossref
Mario Rafael Pagani, Laura Elisabeth Gonzalez & Osvaldo Daniel Uchitel. (2011) Autoimmunity in Amyotrophic Lateral Sclerosis: Past and Present. Neurology Research International 2011, pages 1-11.
Crossref
Melissa NassifSoledad MatusKaren CastilloClaudio Hetz. (2010) Amyotrophic Lateral Sclerosis Pathogenesis: A Journey Through the Secretory Pathway. Antioxidants & Redox Signaling 13:12, pages 1955-1989.
Crossref
Chi-Tso Chiu & De-Maw Chuang. (2010) Molecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disorders. Pharmacology & Therapeutics 128:2, pages 281-304.
Crossref
J. Phukan & O. Hardiman. (2009) The management of amyotrophic lateral sclerosis. Journal of Neurology 256:2, pages 176-186.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.